Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Sep 2025 value amounting to $391.4 million.

  • Madrigal Pharmaceuticals' Total Current Liabilities rose 120.08% to $391.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.4 million, marking a year-over-year increase of 120.08%. This contributed to the annual value of $169.3 million for FY2024, which is 42.79% up from last year.
  • Madrigal Pharmaceuticals' Total Current Liabilities amounted to $391.4 million in Q3 2025, which was up 99.19% from $196.5 million recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Total Current Liabilities registered a high of $391.4 million during Q3 2025, and its lowest value of $48.8 million during Q1 2021.
  • In the last 3 years, Madrigal Pharmaceuticals' Total Current Liabilities had a median value of $125.2 million in 2024 and averaged $159.8 million.
  • Data for Madrigal Pharmaceuticals' Total Current Liabilities shows a peak YoY spiked of 120.08% (in 2025) over the last 5 years.
  • Madrigal Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $76.8 million in 2021, then surged by 50.83% to $115.9 million in 2022, then grew by 2.29% to $118.5 million in 2023, then surged by 42.79% to $169.3 million in 2024, then surged by 120.08% to $391.4 million in 2025.
  • Its Total Current Liabilities stands at $391.4 million for Q3 2025, versus $196.5 million for Q2 2025 and $167.2 million for Q1 2025.